REPLIMUNE GROUP, INC. Operating Income
REPLIMUNE GROUP, INC. (REPL) reported Operating Income of -$68.25 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-14
- REPLIMUNE GROUP, INC. operating income (loss) for the quarter ending 2026-06-30 was -$68.25M.
- REPLIMUNE GROUP, INC. operating income (loss) for the quarter ending 2026-03-31 was -$73.34M.
- REPLIMUNE GROUP, INC. operating income (loss) for the quarter ending 2025-12-31 was -$71.87M.
- REPLIMUNE GROUP, INC. operating income (loss) for the quarter ending 2025-09-30 was -$84.29M.
- REPLIMUNE GROUP, INC. operating income (loss) for fiscal 2026 was -$319.92M.
- REPLIMUNE GROUP, INC. operating income (loss) for fiscal 2025 was -$261.63M.
- REPLIMUNE GROUP, INC. operating income (loss) for fiscal 2024 was -$234.77M.
- REPLIMUNE GROUP, INC. operating income (loss) for fiscal 2023 was -$177.08M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$68.25M 10-Q · filed 2026-08-14 | -$141.59M derived: sum of 2 quarters · filed 2026-08-14 | -$213.45M derived: sum of 3 quarters · filed 2026-08-14 | -$297.74M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | -$73.34M derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-29 | -$145.21M derived: sum of 2 quarters · filed 2026-06-29 | -$229.50M derived: sum of 3 quarters · filed 2026-06-29 | -$319.92M 10-K · filed 2026-06-29 |
| 2025-12-31 | -$71.87M 10-Q · filed 2026-02-03 | -$156.16M derived: sum of 2 quarters · filed 2026-02-03 | -$246.58M 10-Q · filed 2026-02-03 | -$325.91M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-09-30 | -$84.29M 10-Q · filed 2025-11-06 | -$174.72M 10-Q · filed 2025-11-06 | -$254.04M derived: sum of 3 quarters · filed 2026-08-14 | -$320.06M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$90.42M 10-Q · filed 2026-08-14 | -$169.75M derived: sum of 2 quarters · filed 2026-08-14 | -$235.77M derived: sum of 3 quarters · filed 2026-08-14 | -$294.69M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$79.33M derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-29 | -$145.35M derived: sum of 2 quarters · filed 2026-06-29 | -$204.26M derived: sum of 3 quarters · filed 2026-06-29 | -$261.63M 10-K · filed 2026-06-29 |
| 2024-12-31 | -$66.02M 10-Q · filed 2026-02-03 | -$124.94M derived: sum of 2 quarters · filed 2026-02-03 | -$182.30M 10-Q · filed 2026-02-03 | -$241.06M derived: sum of 4 quarters · filed 2026-02-03 |
| 2024-09-30 | -$58.92M 10-Q · filed 2025-11-06 | -$116.28M 10-Q · filed 2025-11-06 | -$175.04M derived: sum of 3 quarters · filed 2025-11-06 | -$231.58M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | -$57.37M 10-Q · filed 2025-08-07 | -$116.12M derived: sum of 2 quarters · filed 2025-08-07 | -$172.66M derived: sum of 3 quarters · filed 2025-08-07 | -$236.49M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | -$58.76M derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-22 | -$115.30M derived: sum of 2 quarters · filed 2025-05-22 | -$179.13M derived: sum of 3 quarters · filed 2025-05-22 | -$234.77M 10-K · filed 2025-05-22 |
| 2023-12-31 | -$56.54M 10-Q · filed 2025-02-12 | -$120.37M derived: sum of 2 quarters · filed 2025-02-12 | -$176.02M 10-Q · filed 2025-02-12 | -$229.01M derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-09-30 | -$63.83M 10-Q · filed 2024-11-12 | -$119.48M 10-Q · filed 2024-11-12 | -$172.47M derived: sum of 3 quarters · filed 2024-11-12 | -$214.10M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -$55.65M 10-Q · filed 2024-08-08 | -$108.64M derived: sum of 2 quarters · filed 2024-08-08 | -$150.27M derived: sum of 3 quarters · filed 2024-08-08 | -$191.85M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | -$52.99M derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-16 | -$94.63M derived: sum of 2 quarters · filed 2024-05-16 | -$136.20M derived: sum of 3 quarters · filed 2024-05-16 | -$177.08M 10-K · filed 2024-05-16 |
| 2022-12-31 | -$41.63M 10-Q · filed 2024-02-08 | -$83.21M derived: sum of 2 quarters · filed 2024-02-08 | -$124.08M 10-Q · filed 2024-02-08 | -$156.07M derived: sum of 4 quarters · filed 2024-02-08 |
| 2022-09-30 | -$41.58M 10-Q · filed 2023-11-07 | -$82.45M 10-Q · filed 2023-11-07 | -$114.44M derived: sum of 3 quarters · filed 2023-11-07 | -$144.14M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | -$40.88M 10-Q · filed 2023-08-03 | -$72.86M derived: sum of 2 quarters · filed 2023-08-03 | -$102.56M derived: sum of 3 quarters · filed 2023-08-03 | -$131.81M derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | -$31.99M derived: 10-K 12 month − 10-Q 9 month · filed 2023-05-18 | -$61.69M derived: sum of 2 quarters · filed 2023-05-18 | -$90.93M derived: sum of 3 quarters · filed 2023-05-18 | -$118.31M 10-K · filed 2023-05-18 |
| 2021-12-31 | -$29.70M 10-Q · filed 2023-02-09 | -$58.95M derived: sum of 2 quarters · filed 2023-02-09 | -$86.33M 10-Q · filed 2023-02-09 | -$108.51M derived: sum of 4 quarters · filed 2023-02-09 |
| 2021-09-30 | -$29.25M 10-Q · filed 2022-11-03 | -$56.63M 10-Q · filed 2022-11-03 | -$78.81M derived: sum of 3 quarters · filed 2022-11-03 | -$99.09M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | -$27.38M 10-Q · filed 2022-08-04 | -$49.56M derived: sum of 2 quarters · filed 2022-08-04 | -$69.84M derived: sum of 3 quarters · filed 2022-08-04 | -$89.50M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | -$22.18M derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-19 | -$42.46M derived: sum of 2 quarters · filed 2022-05-19 | -$62.12M derived: sum of 3 quarters · filed 2022-05-19 | -$79.95M 10-K · filed 2022-05-19 |
| 2020-12-31 | -$20.27M 10-Q · filed 2022-02-03 | -$39.94M derived: sum of 2 quarters · filed 2022-02-03 | -$57.77M 10-Q · filed 2022-02-03 | -$74.16M derived: sum of 4 quarters · filed 2022-02-03 |
| 2020-09-30 | -$19.66M 10-Q · filed 2021-11-04 | -$37.50M 10-Q · filed 2021-11-04 | -$53.88M derived: sum of 3 quarters · filed 2021-11-04 | -$70.55M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | -$17.83M 10-Q · filed 2021-08-06 | -$34.22M derived: sum of 2 quarters · filed 2021-08-06 | -$50.88M derived: sum of 3 quarters · filed 2021-08-06 | -$63.12M derived: sum of 4 quarters · filed 2021-08-06 |
| 2020-03-31 | -$16.39M derived: 10-K 12 month − 10-Q 9 month · filed 2021-05-20 | -$33.05M derived: sum of 2 quarters · filed 2021-05-20 | -$45.29M derived: sum of 3 quarters · filed 2021-05-20 | -$56.20M 10-K · filed 2021-05-20 |
| 2019-12-31 | -$16.66M 10-Q · filed 2021-02-04 | -$28.91M derived: sum of 2 quarters · filed 2021-02-04 | -$39.81M 10-Q · filed 2021-02-04 | -$47.64M derived: sum of 4 quarters · filed 2021-02-04 |
| 2019-09-30 | -$12.24M 10-Q · filed 2020-11-05 | -$23.15M 10-Q · filed 2020-11-05 | -$30.98M derived: sum of 3 quarters · filed 2020-11-05 | -$41.11M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | -$10.91M 10-Q · filed 2020-08-07 | -$18.73M derived: sum of 2 quarters · filed 2020-08-07 | -$28.87M derived: sum of 3 quarters · filed 2020-08-07 | -$35.97M derived: sum of 4 quarters · filed 2020-08-07 |
| 2019-03-31 | -$7.83M derived: 10-K 12 month − 10-Q 9 month · filed 2020-06-03 | -$17.96M derived: sum of 2 quarters · filed 2020-06-03 | -$25.07M derived: sum of 3 quarters · filed 2020-06-03 | -$30.95M 10-K · filed 2020-06-03 |
| 2018-12-31 | -$10.14M 10-Q · filed 2020-02-13 | -$17.24M derived: sum of 2 quarters · filed 2020-02-13 | -$23.12M 10-Q · filed 2020-02-13 | -$30.18M derived: sum of 4 quarters · filed 2020-06-03 |
| 2018-09-30 | -$7.10M 10-Q · filed 2019-11-12 | -$12.98M 10-Q · filed 2019-11-12 | -$20.05M derived: sum of 3 quarters · filed 2020-06-03 | -$24.78M derived: sum of 4 quarters · filed 2020-06-03 |
| 2018-06-30 | -$5.88M 10-Q · filed 2019-08-14 | -$12.94M derived: sum of 2 quarters · filed 2020-06-03 | -$17.68M derived: sum of 3 quarters · filed 2020-06-03 | -$21.93M derived: sum of 4 quarters · filed 2020-06-03 |
| 2018-03-31 | -$7.07M derived: 10-K 12 month − 10-Q 9 month · filed 2020-06-03 | -$11.80M derived: sum of 2 quarters · filed 2020-06-03 | -$16.05M derived: sum of 3 quarters · filed 2020-06-03 | -$19.23M 10-K · filed 2020-06-03 |
| 2017-12-31 | -$4.73M 10-Q · filed 2019-02-14 | -$8.99M derived: sum of 2 quarters · filed 2019-02-14 | -$12.16M 10-Q · filed 2019-02-14 | |
| 2017-09-30 | -$4.26M 10-Q · filed 2018-11-14 | -$7.43M 10-Q · filed 2018-11-14 | ||
| 2017-06-30 | -$3.18M 10-Q · filed 2018-08-30 | |||
| 2017-03-31 | -$9.65M 10-K · filed 2019-06-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B |